Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherMinireview

THE PHARMACOLOGICAL CASE FOR CANNABIGEROL (CBG)

Rahul Nachnani, Wesley M Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics November 9, 2020, JPET-MR-2020-000340; DOI: https://doi.org/10.1124/jpet.120.000340
Rahul Nachnani
1Pharmacology, Penn State College of Medicine, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wesley M Raup-Konsavage
1Pharmacology, Penn State College of Medicine, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kent E. Vrana
2Dept. of Pharmacology, Penn State College of Medicine, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kent E. Vrana
  • For correspondence: kvrana@psu.edu
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

JPET-MR-2020-000340
DOI 
https://doi.org/10.1124/jpet.120.000340
PubMed 
33168643

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online November 9, 2020.

Article Versions

  • You are currently viewing an Earlier version of this article (November 9, 2020 - 12:59).
  • View the most recent version of this article
Copyright & Usage 

Author Information

  1. Rahul Nachnani1,
  2. Wesley M Raup-Konsavage1, and
  3. Kent E. Vrana2,*
  1. 1Pharmacology, Penn State College of Medicine, United States of America
  2. 2Dept. of Pharmacology, Penn State College of Medicine, United States
  1. ↵* Corresponding Author:
    Kent E. Vrana, Dept. of Pharmacology, Penn State College of Medicine, Penn State College of Medicine, 500 University Dr, Hershey, Pennsylvania, 17033-0850, United States. E-mail: kvrana{at}psu.edu

Statistics from Altmetric.com

Article usage

Article usage: November 2020 to May 2022

AbstractFullPdf
Nov 20203790265
Dec 20202810168
Jan 2021263710262
Feb 2021248790198
Mar 20212341136523
Apr 2021226600260
May 2021165819278
Jun 2021197995243
Jul 2021141970206
Aug 20212051058239
Sep 20212231395264
Oct 20211851473337
Nov 20212461669432
Dec 20211161798285
Jan 20221793297357
Feb 20221742875334
Mar 20222253116461
Apr 20222452470349
May 20221701273199

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE PHARMACOLOGICAL CASE FOR CANNABIGEROL (CBG)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherMinireview

Potential Clinical Uses of CBG

Rahul Nachnani, Wesley M Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics November 9, 2020, JPET-MR-2020-000340; DOI: https://doi.org/10.1124/jpet.120.000340

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherMinireview

Potential Clinical Uses of CBG

Rahul Nachnani, Wesley M Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics November 9, 2020, JPET-MR-2020-000340; DOI: https://doi.org/10.1124/jpet.120.000340
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Generic Substitution of Antiseizure Medications
  • Potential Therapeutic Approaches to Nociplastic Pain
  • Attenuation of Drug Response with Repeated Doses
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics